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High experienced continuity of care in patients with cancer is associated with lower needs for care, better quality of life and better
psychological outcomes. We developed and evaluated an intervention to improve experienced continuity. The intervention,
consisted of (1) a 17-item patient-completed continuity assessment; (2) feedback to clinical nurse specialists and action to address the
needs identified. Multidisciplinary team meetings and oncology outpatient clinics were observed, and patients and staff were
interviewed. After qualitative work and reliability testing, the intervention was evaluated in a feasibility trial. Sixty-one patients
provided data for analysis. No statistically significant differences were found in patients’ experienced continuity between the trial arms,
but important trends were seen in measures of needs for care in favour of those receiving the intervention. Feeding back findings
from the continuity assessment to clinicians reduced patients’ needs for care. Our results indicate that an intervention to target
patients’ experiences of continuity can reduce their subsequent needs for care. However, overcoming barriers to organisational
change and addressing some patients’ hesitation to report their continuity difficulties must be considered when implementing such an
intervention. A phase III trial targeting patients with inadequate experienced continuity of care is recommended.
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As survival rates for cancer improve, continuity of care in patients
with cancer is becoming a research priority (Department of Health,
2007). The Department of Health in England has recently launched
the Cancer Survivorship Initiative, and continuity of care is one of
the key themes to be explored (Department of Health, 2008). Many
cancers are now experienced as a chronic disease and survivors
may fear recurrence, feel out of touch with service providers and
experience feelings of uncertainty. The National Institute for
Clinical Excellence’s guidance on Supportive and Palliative Care
(NICE, 2004) recommended promoting mechanisms to enhance
continuity of care, and observed that few studies have researched
the ‘impact of continuity of care on the process and outcomes of
care’.
In earlier research, we used a combination of methods to
identify the importance of experienced continuity for patients with
breast, lung and colorectal cancer at all phases of disease (King
et al, 2008). We concluded that continuity is a concept best defined
by how it is experienced by patients rather than how it is delivered
by services. We also found that higher experienced continuity is
associated with lower future needs for supportive care and better
psychological outcomes. This research was part of a wider
programme commissioned by NIHR Service and Delivery Organi-
sation to explore concepts of continuity of care in chronic disease.
Findings from the programme were synthesised and combined
with evidence from the international literature, in particular from
work conducted in Canada (Freeman et al, 2007). The analysis
concluded that patients should be encouraged to behave, as
partners in their care and professionals should aim to work with
patients rather than simply delivering a service to them. Few
studies have attempted to evaluate mechanisms for improving
continuity of care in cancer. These have focussed largely on service
delivery and attempted to improve co-ordination of care through
new care models to join up services (Smeenk et al, 1998), provision
of additional support from secondary to primary care profes-
sionals (Johansson et al, 1999) and the introduction of nurse co-
ordinators for patients in the last year of life (Addington-Hall et al,
1992). None of these interventions has shown patient benefit.
Continuity as experienced by patients may incorporate the three
elements of continuity (informational, management and relation-
ship) described previously (Haggerty et al, 2003). Recent devel-
opment of care pathways and guidelines may improve
informational and management continuity, but will not influence
relationship continuity (Guthrie et al, 2008).
We used our findings to formulate an intervention to improve
continuity of care that was patient centred. In this study, we report
on further development of this intervention and its performance in
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sa feasibility randomised controlled trial. The intervention con-
sisted of two parts: (1) a patient completed 17-item continuity
assessment and (2) feedback to staff of patients’ responses to the
assessment.
MATERIALS AND METHODS
Development of the intervention
This study was conducted in breast, lung and colorectal cancer
services at four North London NHS Trusts. Additionally, two
palliative clinics and two multidisciplinary team meetings were
observed at a North London Marie Curie Hospice. Ethical approval
was obtained from East London and the City Multisite Research
Ethics Committee 1 on 23 May 2006.
We observed clinics and multidisciplinary team meetings and
conducted semistructured interviews with staff and patients to:
1. Inform the timing of, the people with whom, and the context
within which the intervention would be delivered.
2. Obtain professionals’ and patients’ views on the acceptability
and practicability of delivering and receiving the intervention.
Observations of clinics and multidisciplinary team meetings Our
initial plan was for each patient’s experienced continuity to be
reviewed at multidisciplinary team meetings. Two project
researchers explored the feasibility of this idea by observing
breast, lung and colorectal multidisciplinary team meetings and
outpatient clinics. Our objectives were to observe the content of
the multidisciplinary team meetings and interactions between
team members. We focused on patient-centred issues (e.g., their
history or social circumstances), which we knew were likely to
impact on continuity of care (King et al, 2008). We considered the
possible content and timing of a continuity assessment and how it
might be presented at the multidisciplinary team meeting. Our
observations of clinic consultations and staff meetings aimed to
identify how gaps in continuity of care were identified and
managed by staff.
Staff interviews We conducted semistructured interviews with
five clinical nurse specialists (CNS), three consultant medical
oncologists, two specialist registrars and two research nurses all of
whom worked in services for the three cancer types at the
participating NHS Trusts. The interviews focused on the structure,
content and format of the proposed intervention, the possible
timing and setting of its delivery, and which member of staff might
be best placed to undertake it. We also asked participants to
consider how they might manage issues arising from the
continuity assessment.
Patient interviews We assessed the views of patients with breast,
lung or colorectal cancer on the structure and content of the
continuity assessment. We approached outpatients opportunisti-
cally in each of the five phases of cancer treatment: recently
diagnosed, following initial treatment, remission, recurrence and
palliative care. After giving informed consent, patients completed
the continuity assessment without assistance and were then
interviewed in private to discuss the structure and content of the
questionnaire. To assess test–retest reliability of the assessment,
patients were asked to complete the questionnaire again at home
after 2 weeks and return it by post.
Iterations of the continuity assessment The continuity assessment
was developed through two iterations. Version 1 consisted of a
continuity assessment composed of four domains that we had
developed in earlier work (King et al, 2008). We had planned that
the assessment would be completed by clinicians and presented at the
multidisciplinary team meeting to inform team decision making.
However, because nurses felt strongly that they had insufficient time to
help patients complete the assessments, we concluded that the
continuity assessment should be entirely patient focussed. Thus, we
developed a second version for patient self-completion that contained
18 items from our earlier work (King et al, 2008), and six additional
items from Version 1. Responses to patient’s first and second
assessments were entered into STATA release 9 and analysed using
the k-statistic. Items with low reliability were dropped, which resulted
in 17 items in a final version.
Continuity intervention tested in the feasibility trial
The intervention had two components:
1. Component 1: The patient-completed 17 item continuity
assessment (Box 1). After each item, patients ticked a box if
they wished to discuss the issue further with a clinical team
member. Four boxes were given at the end of the questionnaire
in which participants could also write any additional informa-
tion they wanted to give on up to four items.
2. Component 2: Feedback of patients’ responses (component 1)
to CNS and their reporting of any action taken by services.
Work with staff before the feasibility trial We met CNS staff to
discuss the objectives of the feasibility trial, hear any concerns,
clarify its purpose and stress its importance. We explained that we
would first ask patients to complete the continuity assessment, and
then, with their permission, pass on their responses to the CNS
involved in their care. Nurses were asked to complete a clinical
feedback form briefly detailing any action they had taken in
response (see trial arms below).
Feasibility randomised controlled trial
We obtained ethical approval for this part of the study from East
London and the City Local Research Ethics Committee 1 on 30
May 2007. Our objectives were to:
1. Decide on appropriate outcome measures for a Phase III trial.
2. Explore changes in such outcomes in the trial.
Box 1 Statements on experienced continuity of care
Item
no. Items
1 I have received enough time and attention from the cancer services.
2 I feel I am seeing the cancer services often enough.
3 I am getting consistent information about my illness from health care
staff.
4 I frequently have to chase up cancer services to get things done.
5 I have been well informed about what my treatment will involve over
the next few months.
6 I feel out of touch with the cancer services between appointments.
7 I feel I am supported by the people closest to me.
8 I feel the people closest to me are able to cope with my illness.
9 I am worried about the emotional state of the people closest to me.
10 I feel I depend too much on the people closest to me.
11 I have received some misleading information from the cancer
services.
12 I am satisfied that I have received a full medical examination with
regard to cancer.
13 I am worried that some things may have been overlooked.
14 I know I have a specific person at the hospital whom I can contact
when I need to.
15 I know how to contact this person.
16 The last time when I was in clinic, I think the clinical staff had all my
notes.
17 I feel I am able to manage between appointments.
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s3. Obtain professionals’ and patients’ views on the acceptability
and practicality of delivering and receiving components of the
intervention.
4. Demonstrate acceptable recruitment and retention rates.
Recruitment
Patients were recruited from outpatient clinics and the chemother-
apy suite of one NHS Trust in North London from 12 June to 25
October 2007. Patients were eligible for inclusion if they had
breast, lung or colorectal cancer, had reached the end of first
treatment, were able to give informed consent and were aged over
17 years.
Randomisation An independent statistician used a blocked
randomised design to achieve equal numbers in each trial arm.
Researchers telephoned the trial centre to receive each partici-
pant’s allocation from an administrator independent of the trial.
The researchers were masked to block size, but not to patient
allocation.
Trial arms All patients received usual care.
Arm 1: No continuity intervention.
Arm 2: Completed the continuity assessment (the partial
intervention).
Arm 3: Completed the continuity assessment plus their
responses were fed back to the CNS who were
expected to take action as necessary in any areas
highlighted by patients for further attention (the full
intervention). This could involve discussion with
patients and/or discussion between members of the
team. We did not indicate how or when actions should
be taken; rather we left that to the CNS’s expertise.
Because our discussions with CNS in the preparatory
phases of the study suggested that obtaining doc-
umentation on their actions would be difficult, we
designed clinical feedback forms that were as brief
and simple to complete as possible.
Baseline assessments Patients in trial arm 1 completed no
assessments at baseline. Patients in trial arms 2 and 3 completed a
need assessment (the supportive care needs survey, (SCNS), which
covers psychological, physical, sexuality, patient care and health
system domains (Bonevski et al, 2000)). They also completed the
same visual analogue scales to measure satisfaction that we had used
in our earlier cohort study (King et al, 2008). No standardised scales
exist to measure satisfaction with continuity of care, and thus visual
analogue scales are a viable alternative and are particularly useful for
measuring change over time in each individual.
Follow-up assessments Patients in all three arms completed the
continuity assessment (primary outcome), and the needs assess-
ment and satisfaction rating (secondary outcomes) by post after
6 weeks. Non-responders were sent one reminder after 2 weeks.
Statistical analysis We evaluated the randomisation by
comparing centre and patients’ demographic and clinical character-
istics in each trial arm. We compared baseline data with the different
components of the intervention in trial arms 2 and 3. Data from
clinical feedback forms in arm 3 were analysed descriptively. Linear
and logistic regression models were used to examine associations
between covariates and outcomes at baseline. Responders and non-
responders at follow-up were compared using logistic regression.
Differences in outcome between arms 1 and 2 were examined using
multivariable linear regression for continuous outcomes and logistic
regression for binary outcomes. Where there were no differences,
arms 1 and 2 were combined into one comparison group for further
analysis. Differences between intervention and comparison arms
were then examined using linear and logistic regression as above. We
did not estimate sample size for this feasibility trial. Rather, we
estimated the likely effect sizes of the intervention (arms 1 vs 2a n d
arms 1 vs 3) to guide sample size estimations for a full-scale
randomised trial. We did not have sufficient power to examine the
effect of covariates, such as degree of advanced cancer or location.
However, we used multivariable regression to explore further the
relationship between continuity, sociodemographic characteristics
and SCNS needs for care at baseline and outcome in participants in
trial arms 2 and 3.
RESULTS
Clinic observations
Twenty-nine clinics were observed (six breast, 13 lung and 10
colorectal oncology outpatient clinics). Three main themes
emerged from our clinic observations:
1. Continuity of care appeared to be considered with most
patients.
2. The CNS is most likely to influence continuity.
3. Issues of continuity did not vary greatly between NHS Trusts or
tumour types.
Multidisciplinary team meeting observations
Thirty-two meetings were attended (10 breast, 13 lung and nine
colorectal). Four main observations emerged:
1. Meetings vary in structure and content according to tumour
type and NHS Trust.
2. Meetings may be dominated by individuals with strong
personalities.
3. Meetings vary in use of technology, such as viewing electronic
records and radiological and pathological findings.
4. Continuity of care is addressed occasionally.
Staff interviews
Twelve healthcare professionals were asked for their views on
version 1 of the continuity assessment. Few clinicians felt that
multidisciplinary team meetings were the appropriate venue for
consideration of this assessment mainly because:
1. Of insufficient time and staff resistance to the extra responsi-
bility.
2. Several professionals would not know the patient in any
personal way.
3. Multidisciplinary team meetings were considered too medical.
Clinicians also felt their work load would not accommodate the
time it would take to complete the assessment with the patient.
Patient interviews
Thirty-eight patients were interviewed about the revised, patient-
centred continuity assessment. Forty-five percent of patients
thought that most of the items were very important and relevant,
whereas the remaining 55% regarded the items in varying degrees
of less importance. The main issues patients felt were overlooked
concerned service delivery and organisation, such as waiting times,
difficulties with appointments and communication between
services. The majority of patients (35 out of 38) thought that
both the length and content of the assessment were adequate and
none were opposed to any item. Four patients suggested that there
should be more specific items on the emotional aspects of
the patients’ cancer experience. One participant suggested that
there should be an item touching on the consequences of how
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sone’s ‘structure of life’ changes after diagnosis, for example, having
to depend on a spouse. A few patients considered some items too
complex to respond to simply with a ‘yes’ ‘no’ or ‘cannot say’. Most
of the participants thought the assessment should be administered
towards the beginning of treatment, although not too soon after
diagnosis (before patients can cope emotionally), and not so late
that potential gaps in continuity would be missed, and most of
them recognised that they needed time to get used to service and
come to terms with their emotional and service-oriented needs.
Pretrial work with CNS
Clinical nurse specialists often regarded the continuity issues in
the questionnaire as covered already or generating extra work, and
some thought that the responses might be perceived as criticism of
their role. These results suggested that we might have difficulty
ensuring documentation of the clinical response component of the
intervention in the feasibility trial.
Feasibility trial
Of the 145 patients assessed for eligibility, 26 (18%) did not meet
the inclusion criteria and 28 (19%) refused to participate. Main
reasons for refusal were unable to give informed consent (poor
English or illiteracy); not interested; too frail or unwell; too
worried about their current clinic visit and visual impairment. This
resulted in 93 patients (64% of those assessed) randomised into the
study. There were no significant differences in patient character-
istics between the three arms of the trial. The mean age overall was
59 years. Almost half (45%) of the patients had breast cancer,
which is reflected in the high proportion of women in the trial
(73%). Just over half (55%) of patients were White British and 86%
spoke English as a first language. Over half (56%) of the patients
were partnered, with 63% educated beyond the GCSE level, which
is a basic school education. Of the 57 patients in trial arms 2 and 3
who completed a continuity assessment at baseline, 43 (74%)
indicated at least one area of poor continuity, but of these, only 13
(30%) ticked the box indicating that they wanted to discuss issues
further with their CNS. Patients in arms 2 and 3 who did not wish
to discuss their continuity difficulties at baseline had significantly
higher SCNS physical needs.
Response to follow-up
A total of 61 (66%) patients completed the outcome assessments.
Attrition was highest in the 32 patients randomised to the partial
intervention arm only (arm 2, Figures 1 and 2). Most (81%) of
those lost to follow-up were patients who failed to respond. A small
number died, and two refused to complete the follow-up
questionnaires. Patients in the intervention groups were signifi-
cantly more likely to drop out than those in arm 1 (arm 2: OR: 6.25,
P¼0.004, arm 3: OR: 3.75, P¼0.042). Those with GCSE level
education were significantly more likely to drop out than those
with degree level education (OR: 2.98, P¼0.042).
Differences between trial arms at follow-up
Experienced continuity, as measured by the patient completed
continuity assessment (component 1 of the intervention) was high,
with a mean score of 15 (17 is the highest score possible) and
varied little between the three trial arms (Table 1). Satisfaction, as
measured by the VAS, was generally high with an average score of
82%, which differed little between trial arms. There was a clear
trend towards lower scores in all categories of the SCNS
(psychological, physical, health system, patient care and sexuality)
from the control group that had the highest level of unmet need to
the full intervention arm that had the lowest level of need (Table 1)
at the follow-up.
At follow-up, patients in the intervention arms were more likely to
request further discussion of issues than those in the control arm.
Not all documentation of CNS activity in response to the continuity
assessment was received (15 of 30 were returned), and thus for many
patients, we do not know what extra action was taken or if the
continuity assessment affected CNS input to their care.
Further assessment of patients’ experienced continuity,
SCNS needs and satisfaction
We further examined participants in trial arms 2 and 3 who
completed assessments at baseline and follow-up. These could be
grouped on the basis of their responses to the continuity
assessment at baseline:
1. No difficulties highlighted on the continuity assessment
(14 patients).
2. Participants indicated difficulties but did not want to discuss
them with staff (30 patients).
3. Participants indicated difficulties and wanted to discuss them
with staff (13 patients).
Non-white patients were more likely to indicate continuity
difficulties, but were less likely to want to discuss them further
(Table 2). A similar association was found for language status.
Patients who indicated at baseline that they wanted to discuss
continuity issues further had higher SCNS physical needs at
follow-up than those who had noted difficulties, but had not
wanted to discuss them (Table 3). This was after adjustment for
baseline SCNS needs. Patients who had not wanted to discuss their
continuity difficulties at baseline had higher SCNS psychological
needs and lower satisfaction at follow-up than those who had no
continuity difficulties at baseline (Table 3).
DISCUSSION
Main findings
We used findings from our earlier research, as well as staff and
patients’ views, to develop and refine our intervention to improve
continuity, which was then tested in a feasibility trial. Three quarters of
patients assessed at baseline (trial arms 2 and 3) indicated at least one
area of poor continuity, but only one-third of these patients indicated
they wanted to discuss issues further with their CNS. The full
intervention (arm 3) involved patients’ assessment of their own care,
which was fed back for action by CNS. Although there was no
measurable change in experienced continuity, there were consistent
trends in needs for care in favour of the intervention arms, with those
in the full intervention expressing least unmet needs for care. This
mirrors our findings in earlier research where high experienced
continuity was associated with lower needs for care (King et al, 2008).
Some patients (particularly non-white people and those whose first
Patients enrolled after obtaining the informed
consent 
Randomisation 
Arm 1 
Usual care 
Arm 2 
Baseline assessment +
component 1+
usual care
(partial intervention)
Arm 3 
Baseline assessment
+ component 1+ 
component 2
(full intervention)
Figure 1 Flow diagram of the trial.
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slanguage was not English) were more likely to indicate that they had
continuity difficulties, but less likely to want them conveyed to staff.
Participants who had wanted to discuss their continuity difficulties at
baseline seem to have generally poorer outcomes than those who did
not want to discuss them or had no continuity difficulties.
Strengths and limitations
The main strength of this study was our ability to combine
findings on continuity from our earlier work (King et al, 2008)
with direct observation of clinics and multidisciplinary
team meetings and interviews with staff and patients. The latter
gave us data on the nature and content of discussions about
continuity of care as well as an opportunity to ascertain how best
to measure continuity of care, and implement interventions in
these settings. The work also included further development of a
measure of continuity and a pilot randomised controlled trial
exploring feasibility of increasing experienced continuity in a
clinical setting.
There were also a number of limitations. Our trial was of low
statistical power as its main aim was to assess whether a
randomised evaluation of a continuity intervention was possible
in this setting. However, the data are an important indication of
the sorts of changes we might expect if this evaluation were to be
rolled out in a phase III randomised trial. The findings themselves
will also be useful in future systematic reviews of trials to evaluate
continuity interventions. It is important to publish the results of
small trials because the data, although not significant in their own
right, will contribute to the findings of a subsequent meta-analysis.
Not to publish them contributes to the publication bias
encountered in many systematic reviews.
Despite our finding that patients who received the partial
intervention (trial arm 2) showed a trend towards poorer outcomes
than those receiving the full intervention (trial arm 3), we were
unable to collect consistent information on input by CNS staff.
Receipt of assessments from patients may indeed have altered staff
behaviour, whether or not it was recorded or fed back to the
research team.
The commonest limitation expressed by staff was lack of time
due to pressure of work. Complaints of lack of time when
organisational change is suggested may be a consequence of staff
Assessed for eligibility
(n=145) 
Enrolment 
Excluded (n=52)
Not meeting inclusion 
  criteria  (n=26)
Refused to participate 
(n=28) 
Randomised
(n=93)  
Allocated to Arm 1 
(control)
(n=29) 
Allocated to Arm 3 
(full intervention) 
(n=32)
Allocated to Arm 2 
(partial intervention) 
(n=32)
Lost to follow-up (n=4) 
 Non-responders (n=3)
 Death  (n=1)
 Refusals  (n=0)
Lost to follow-up  (n=16) 
Non-responders (n=15)
 Death  (n=0)
Refusals (n=1)
Lost to follow-up  (n=12) 
 Non-responders (n=8)
 Death  (n=3)
 Refusals  (n=1)
Analysed (n=16)
Excluded from analysis
(n=16)
Analysed (n=25)
Excluded from analysis
(n=4)
Analysed (n=20)
Excluded from analysis
(n=12)
Figure 2 Consort diagram of the flow of the trial.
Table 1 Outcome measures at 6-week follow-up
Arm 1 Arm 2 Arm 3 Total
SCNS
a mean (s.d.)
Psychological 45 (34) 37 (19) 32 (28) 39 (29)
Physical 41 (32) 33 (27) 29 (25) 35 (29)
Health system 34 (24) 26 (16) 22 (19) 28 (21)
Patient care 28 (22) 25 (20) 20 (17) 24 (20)
Sexuality 23 (26) 19 (21) 18 (29) 20 (25)
Satisfaction
b mean (s.d.) score 83 (19) 83 (19) 80 (23) 82 (20)
Continuity assessment score
(mean s.d.)
15 (4) 15 (3) 15 (3) 15 (3)
At least one difficulty reported
on continuity assessment
11 (38%) 19 (59%) 15 (47%) 45 (48%)
SCNS¼supportive care needs survey s.d.¼standard deviation.
aSCNS is scored out
of 100; 100 indicating high level of need.
bSatisfaction, as measured by the visual
analogue score, is scored out of 100, higher scores indicating a higher level of
satisfaction.
cThe continuity assessment, is scored out of 17, 17 indicating good
continuity
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sfeeling undervalued, disempowered or not heard by senior staff
(Iles and Sutherland, 2001). The difficulties perceived by CNS in
this trial may reflect deeper problems relating to their perceived
role within the multi-disciplinary team.
It is not clear why attrition was highest in arm 2 (partial
intervention). It cannot be due to repeated requests, as this would
have affected arm 3 similarly. It is possible that participants in arm
2 expected that something would be done in response to
completing the assessment, and when that was not the case,
decided they did not want to continue in the study. This may also
have been the explanation for why participants who had wanted to
discuss their continuity difficulties at baseline seem to have poorer
outcomes than those who did not want to discuss them or had no
continuity difficulties. It may have occurred because their
expectations that something would happen were not met.
Although based on our earlier research across three London
cancer networks (King et al, 2008), this phase II work was
conducted in only one network in London. Cancer services
nationally work to agreed standards and targets set by the
Department of Health, and are subjected to frequent peer review.
However, London healthcare has been observed to be less adequate
than other parts of the United Kingdom in terms of quality of care
achieved (Darzi, 2007).
Theoretical model
Our findings support the underlying theoretical framework that
arose from our earlier work (King et al, 2008), namely that (1)
patients’ experience of continuity is an outcome of service delivery
that can be facilitated rather than provided by professionals; (2)
patients should be enabled to take control of their continuity and
ensure that they feel supported and ‘in contact’ with services
between appointments and (3) staff should receive feedback from
patients on their experienced continuity so that they can respond
in whatever clinical manner fits with their knowledge, experience
and training. We now need to take that model forward with a
broader evaluation.
Recommendations for further work
Given that we showed important trends towards lower needs for
care for all patients who received the full intervention, targeting
only those patients reporting less than adequate continuity at
baseline might show even greater effects in a full trial. It could be
argued that in a phase III randomised trial, the intervention might
best be targeted at patients who have continuity difficulties and a
desire that these difficulties are fed back to staff. This might also
mean that CNS would be more responsive in giving feedback on
their actions to the trialists as they would only have to review the
continuity assessments of patients with difficulties rather than all
patients, as was the case in trial arm 3. However, such a conclusion
may be premature. As we have discussed, only one-third of
patients who had indicated continuity difficulties stated that this
should be fed back to their CNS, and this desire was lowest in black
and minority ethnic patients and those whose first language was
not English. Thus, we might need first to encourage all patients to
venture such feedback, because it is in their best interests to do so,
but also particularly to encourage patients in vulnerable groups to
do so.
Our results also show how important it is to engage all members
of staff who are likely to be affected. Although we made
considerable efforts to engage staff, greater staff education and
support would be essential for a definitive trial. Staff at all levels
should understand the background and importance of the
research, as well as the likely benefits for patients. Engaging an
influential clinician who might champion the innovation within
each participating service would be a considerable help. A recent
systematic review concluded that opinion leader interventions
reduce non-compliance with desired clinical practice. However,
identifying appropriate leaders can be labour intensive and
unreliable (Doumit et al, 2007). Nevertheless, given that continuity
of care is a central plank of the Cancer Reform Strategy (DOH,
2007), promotion of internal leadership should be possible. Robust
research into improving continuity is essential to inform future
policy. There is evidence that in long term, life-threatening
illnesses, such as cancer, preservation of trust and hope within
the professional-patient relationship, is crucial in determining
whether or not patients make best use of effective treatments
(Barnes et al, 2007). Our results show that attention to experienced
continuity may lead to better patient outcomes. They also show
that the key barriers to efforts to improve continuity are
organisational and patient centred. By the latter, we mean the
hesitation on the part of some patients to report their continuity
Table 2 Demographic characteristics in relation to continuity at baseline for trial arms 2 and 3
No difficulties
highlighted on the
continuity assessment
Participants indicated
difficulties but did not want
to discuss them with staff
Participants indicated
difficulties and wanted
to discuss them with staff Statistics
Ethnicity
White-British 10 (36) 10 (36) 8 (29) X
2 (2df)¼7.27
Other 5 (18) 20 (71) 3 (11) P¼0.026
First language
English 15 (31) 22 (46) 11 (23) Fisher’s exact test
Other 0 8 (89) 1 (11) P¼0.036
Number (%).
Table 3 Relationship between response to continuity assessment at
baseline (trial arms 2 and 3) and outcomes
Regression
coefficient
95% confidence
interval P-value
Physical needs SCNS
3 vs 2
a  15  28  2 0.024
Psychological needs SCNS
2 vs 1 29 10 49 0.004
Satisfaction
2 vs 1  20  34  5 0.011
SCNS¼supportive care needs survey.
a1. No difficulties highlighted on the continuity
assessment (14 patients). 2. Participants indicated difficulties but did not want to
discuss them with staff (30 patients). 3. Participants indicated difficulties and wanted
to discuss them with staff (13 patients).
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sdifficulties to the service. We cannot be sure whether this is
because they do not regard reporting them as helpful or whether
they fear criticising the service. Nevertheless, we believe that a
patient-led continuity intervention of this sort is workable. We also
consider that the key staff members, such as CNS, are well placed
to do this work and they felt so too. However, they were stressed
with workloads, and we believe that if this was seen as a priority by
the service, it might take off. Receiving back 50% of CNS’ feedback
forms indicates a degree of success, given the lack of any clinical
champion for continuity in the services.
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